Category Archives: Cardiology

MEDIS expands into new areas of cardiovascular disease with the acquisition of Italian medtech company AMID

LEIDEN, Netherlands, 11-May-2020 — /EPR HEALTHCARE NEWS/ — MEDIS, a leading developer and supplier of software applications for image-based diagnosis and quantitative assessment of cardiovascular disease, today announced that it acquired Advanced Medical Imaging Development S.r.l. (AMID), a developer and supplier specialized in cardiovascular mechanics and innovative image processing in ultrasound and other modalities. The strategic acquisition will expedite MEDIS’ expansion in new areas of cardiovascular disease, and secure MEDIS’ access to key technologies to further enhance its innovative portfolio of post-processing solutions for X-ray, MR, CT, IVUS, OCT and US devices.

The acquisition of AMID, based in Sulmona (Italy), will further increase MEDIS’ share in the cardiovascular market. “This acquisition expands our product portfolio and brings in new sales channels. The combination of AMID’s products with our product and services portfolio will enable us to provide our customers a unique and more complete multi-modal offering for cardiovascular imaging analysis”, said Hans Brons, CEO of MEDIS.

“As part of MEDIS we will have significantly more leverage to position our portfolio of innovative technologies in the global market for cardiovascular imaging software,” commented Giovanni Tonti, CEO of AMID. “Our technology offerings will allow MEDIS to complement and further enhance its already impressive suite of clinical offerings and spur innovation.”

“MEDIS and AMID have already had an excellent cooperation for over five years, both commercially and in product development. I am very excited about our access to the unique know-how and innovative power of AMID’s founders and their technology, and to intensify the cooperation leading to new solutions that ultimately will benefit the patients“ says Hans Reiber, founder and CSO of MEDIS.

MEDIS will leverage AMID’s proprietary state-of-the-art software and know-how to provide even more sophisticated cardiac and cardiovascular imaging software solutions to its customers. “The integration of both companies will take place over the next months. We expect to significantly strengthen our power to innovate and are very excited about our new relationships with AMID’s existing OEMs and sales channels” added Hans Brons. “Our new customers will continue to receive the same high quality of service which they have come to expect.”

AMID, which will continue to operate under that name is now a wholly owned subsidiary of MEDIS.

Over the last 6 months Van Herk Ventures has made significant further equity investments in MEDIS with the aim to help accelerate the growth of the company and to enable the acquisition of AMID.

“With this investment, Van Herk Ventures enables us to further expand on our position as an independent vendor of high specialty software and a leader in this industry,” stated Hans Brons, CEO of MEDIS.

“We have been intrigued by the broad spectrum of innovations in the cardiovascular imaging domain that MEDIS has created and commercialized over the years, and in particular the more recent exciting and disruptive opportunities in the field of interventional cardiology.

MEDIS has been recognized worldwide as a company that develops high quality software, listening to the needs of the clinicians and researchers and supporting them with new and expanded applications. We believe that there is a great upwards potential in MEDIS and we like to stimulate these developments and see the company grow to the next level. We are therefore very excited about the MEDIS acquisition of AMID,” said Dharminder Chahal, managing director of Van Herk Ventures.

SOURCE: EuropaWire

Medis: The new 4D Flow Module reduces the complexity of HeartMRI scans substantially

LEIDEN, Netherlands, 4-Nov-2019 — /EPR HEALTHCARE NEWS/ — Innovative cardiovascular imaging technology solutions developer Medis today announced a new module for the company’s Medis Suite MR. The new 4D Flow module is intuitive and easy to use, and provides essential, practical tools to enable 4D flow to be incorporated into clinical routine and to allow the measurement of flow volumes from a single 4D flow scan instead of multiple 2D flow scans – reducing complexity and easing the process.

“With 2D flow scans, reconstructions must be planned while the patient is on the table,” said Hans Brons, CEO. “For complex scan protocols, this can be tedious and challenging – and the post-processing can be both time-consuming and complex. With the help of this new module for Medis Suite MR, it is now possible to acquire flow in 4D from a single scan and to create flow plane reconstructions retrospectively, allowing the complexity of HeartMRI scans to be reduced substantially – and also reducing the time it takes. This is especially relevant for paediatric HeartMRI units as well as units scanning patients with grown up congenital heart disease.”

Among its numerous differentiators, the new module is advantaged by its ease of use with an intuitive GUI, as well as single click noise removal and single click background offset correction.

As well as reducing the time taken, the new 4D Flow module supports the experienced MR technician in being more effective, more productive and able to deliver better diagnostic information. In addition to reducing the time taken, the new module is straightforward to learn and use for measuring flows in a variety of vessels, allowing the efficient incorporation of 4D Flow post processing in daily clinical practice.

The new 4D Flow module for Medis Suite MR is part of a wide-ranging suite of enhancements for the platform, including the 3D View module – further reducing the time needed for post-processing. In the 3D View module, a double caliper has been added for simple measurements. In addition, loading speed has been increased and it is now also possible to create straightened CPRs (curved planar reformats). Finally, Medis Suite AutoQ pre-processing can now be enabled to run autonomously, initiating Deep Learning contour detection and other advanced algorithms automatically.

Based on over 15 years of experience with cardiac MR, and over 30 years of cardiovascular medical image analysis in general, Medis Suite MR is a vendor-independent post-processing solution for HeartMRI cases. The workflow in Medis Suite MR includes a practical HeartMRI viewer, advanced clinical applications and convenient reporting all in one, making it highly efficient to work with. Seamlessly embedded in the workflow are advanced clinical applications considered best-in-class by many, such as the renowned QMass® and QFlow® applications. In addition, highly innovative and cutting edge research apps such as QStrain RE and QMap RE are also integrated.

Able to run on any workstation, Medis Suite MR is simple to integrate within the hospital IT environment. Connecting it to the DICOM network is straightforward.

4DFlow is cleared for market in the US Market. Clearance approvals for Australia, Brazil, Canada and Europe are pending.

Further information on Medis and its products is available at https://www.medis.nl/

SOURCE: EuropaWire

Europe Home Diagnostics Market: Growth in Pregnancy and Ovulation Predictor Test Kits Sales Encouraging

DUBLIN 2, Ireland, 18-Oct-2018 — /EPR HEALTHCARE NEWS/ — The European home diagnostics industry is realigning to foster integration with the broader customer-centric healthcare services. Growing consumer preference for home-based diagnostics, combined with innovation in online platforms, is creating sustained opportunities in this dynamic landscape. Riding on the coattails of these factors, the US$ 1.4 billion Europe home diagnostics market is likely to grow at 3.4% CAGR during the period 2018-2026.

Consumer Preference for Non-Invasive Glucose Monitoring Devices Still Remains Unmet 

Glucose monitoring kits and devices remain the top-selling product, accounting for over 80% revenue share of the Europe home diagnostics market. The burgeoning demand for home-based glucose monitoring devices and kits can be attributed to growing prevalence of diabetes in Europe, which is increasing across all ages according to the WHO. The Fact.MR study opines that digital devices will remain the preferred choice over cassettes among European consumers.

The broader trends pertaining to non-invasive and painless diagnostics are driving innovation in glucose monitoring device development. According to the Fact.MR study, non-invasive glucose monitoring devices are likely to witness increasing penetration in Europe, albeit at a slow pace. The report also finds that broader innovation in non-invasive devices can drive healthcare consumerism across Europe.

Request a sample of the report

https://www.factmr.com/connectus/sample?flag=S&rep_id=1892

The Fact.MR study remains optimistic on the future growth in Europe’s home diagnostics market, however, challenges prevail. “Self-testing, especially for people with type 1 diabetes, who require daily or frequent testing, remains a painful and inconvenient process. Over the decades, the innovation in glucose monitoring devices hasn’t really addressed the invasive part of the self-testing”, says Mr. Santosh Kumar, Senior Consultant at Fact.MR. “There is an urgent need for non-invasive glucose monitoring testing,” adds Mr. Kumar.

The Fact.MR study finds that home diagnostics manufacturers are aware of the evolving demand. Investment and research into developing minimally or non-invasive home diagnostics devices is gaining ground. “The realization that digital, and non-invasive devices are the future is dawning upon manufacturers. Market leaders, such as Siemens Healthcare and Abbott Technologies are leveraging wearable technologies and IoT to develop innovative products,” says Mr. Kumar.

Growth in Pregnancy and Ovulation Predictor Test Kits Sales Encouraging 

Although glucose monitoring devices and kits will account for the majority of sales, encouraging trends in other self-test kits continue to complement market growth. Pregnancy test kits and ovulation predictor test kits are likely to witness surging demand, as an increasing consumer base feels confident about self-testing. Gains are also encouraging, albeit miniscule, in other home diagnostics products, such as urinary tract infection kits and male infertility test kits.

UK Maintains its Numero Uno Position, Germany and France Remain Lucrative

The Europe home diagnostics market remains concentrated in the UK, Germany, and France. These three markets collectively account for a market share of nearly 60% revenue share of the Europe home diagnostics market. The Fact.MR study opines that these three markets will witness increasing proliferation of next-gen home diagnostics devices.

Request methodology behind the report

https://www.factmr.com/connectus/sample?flag=RM&rep_id=1892

Fact.MR study on the home diagnostics market brings interesting insights to the fore. According to the report, UK remains Europe’s largest market for home diagnostics, with revenues to the tune of US$ 280 million in 2017. The study opines that UK will maintain its numero uno position throughout the course of the forecast period 2017-2026. Germany and France will follow suit, however, sales will grow at a sluggish pace in the former.

The report also finds that home diagnostics devices that use urine and blood for testing will continue to remain pervasive in the Europe home diagnostics market. Samples devices and kits that use semen and breath are expected to witness growth during the course of the forecast period.

Buy the report

https://www.factmr.com/checkout/1892/S

SOURCE: EuropaWire

“Heart Within a Heart” – Surgery Cures 12 Year Old With Rare Congenital Heart Disease

A 12 year old Indian boy successfully underwent open heart surgery for an extremely rare variant of Total Anomalous Pulmonary Venous Connection (TAPVC) at Sri Muthukumaran Medical College and Research Institute, Mangadu, Chennai.

Prabhakaran, a ‘blue baby’ born with a heart birth defect seen in only 1 out of every 500,000 births, had 2 “hearts” inside his chest, one within the other. This complexcongenital heart disease is so rare that it merited selection out of 430+ submissions to be presented at the recently concluded international conference of the Indian Association of Cardiothoracic Surgery (IACTS) at Mumbai in February 2013.

In an intricate open heart operation that lasted 5 hours, the cardiothoracic surgical team including Dr.S.Sivasubramanian, Dr.S.Visvakumar and Dr.Meenakshisundaram successfully repaired the defect.

Unable to afford the high cost of treatment, Prabhakaran’s widowed mother searched desperately for assistance with her son’s surgery. His operation was sponsored by theDr.Mani Children Heart Foundation, a Chennai-based NGO which has funded 100 heart surgeries for under-privileged children with congenital heart disease since its inception in 2003.

In the defect, a rare intracardiac sub-type of TAPVC, all 4 veins returning oxygen-rich blood from the lungs drained into a common chamber (the “pulmonary confluence”) – forming a mini-heart behind the regular heart.

This mini-heart then pumped blood into the atrium through a hole in the heart called an Atrial Septal Defect (ASD), making him a cyanotic ‘blue baby’. Prabhakaran’s surgery was carried out on 16th October 2012. A week later he was discharged from hospital, his lips and fingernails now pink and healthy.

The department of cardiothoracic surgery and cardiology at Sri Muthukumaran Medical College and Research Institute, Mangadu, Chennai has successfully carried out more than 75 operations on patients with valve, coronary and congenital heart diseases in the short period since its inception.

Congenital heart disease (CHD) is rare, with an estimated incidence of 7 to 8 in 1,000 live births. Surgery is often risky and expensive, yet serious complications can arise if treatment is delayed.

For more information about congenital heart defects (CHD), visit the Dr.Mani Children Heart Foundation website at http://www.CHDinfo.com

Via EPR Network
More Healthcare press releases

Clinical Trial Studies New Treatment For High-Risk Heart Patients

A clinical trial under way at the East Carolina Heart Institute is testing the benefit of a new medical device designed to help high-risk people suffering from leaky heart valves.

Dr. W. Randolph Chitwood Jr., director of the Heart Institute and professor of cardiovascular surgery at the Brody School of Medicine at East Carolina University, secured the clinical trial for the MitraClip System for the treatment of mitral valve regurgitation (MR). A serious heart condition, MR can lead to arrhythmias and congestive heart failure if left untreated.

Dr. Curtis Anderson, a cardiothoracic surgeon and assistant professor of cardiovascular sciences, and Dr. Ramesh Daggubati, a cardiologist and clinical professor at Brody, collaborated to perform mitral valve repairs on two patients at Pitt County Memorial Hospital without making the traditional incision in the center of the chest to access the heart. Chitwood joined Drs. Rajasekhar Nekkanti and John Cahill, ECU cardiologists, to assist in the procedure.

In each case, the multidisciplinary team of cardiologists and surgeons placed a thin catheter in the patient’s groin vessel, guided a tiny clip through the heart’s septum and placed the clip between the leaflets of the valve to stop the leak.

“With mitral insufficiency, we normally use the heart/lung machine to either repair or replace the valve,” Chitwood said. “This new procedure is catheter-based, and can be used in high-risk patients who wouldn’t do well on the heart/lung machine. These patients have severe symptoms stemming from the leaky valve and can’t be operated on safely any other way.”

Chitwood said this new procedure “gives the East Carolina Heart Institute an entirely new set of tools for mitral valve repairs in high-risk patients. It is the least invasive way that we can fix a valve. Centers selected to perform these procedures have demonstrated expertise in applying new medical technology under FDA (Food and Drug Administration) guidelines.”

With the clip, patients leave the hospital the next day and within two or three days return to normal activities – or, in many cases, better-than-normal activities.

“Most of the patients are very sick,” said Daggubati, a clinical associate professor of cardiovascular sciences. “Medical management is the only option for them because surgeons consider the risk too high and the patients inoperable.”

Anderson said patient selection is the key to a successful outcome.

“I think a lot of patients with heart failure will be attractive candidates for this device,” he said, adding that collaboration among physicians is vital. “We want patients to have the confidence of knowing that cardiologists and cardiac surgeons are working side by side to give them the best possible outcomes.”

The mitral valve is a one-way valve that connects the left atrium to the left ventricle of the heart. With mitral valve regurgitation, the valve does not seal completely, and blood leaks back into the left atrium. This reversed flow can cause heart and lung damage, as well as death. Symptoms may include an audible heart murmur, shortness of breath and heart palpitations.

About the East Carolina Heart Institute
The East Carolina Heart Institute is a unique partnership that includes University Health Systems Pitt County Memorial Hospital and East Carolina University, along with cardiovascular experts in private practice, academic medicine and research. The East Carolina Heart Institute is the first in North Carolina devoted exclusively to education, research, treatment and prevention of cardiovascular diseases.

Via EPR Network
More Healthcare press releases

Quoteboffin.co.uk Encourages Heart Attack Survivors To Speak To Doctors About Sex Fears

A recent study has drawn attention to the large number of people who are scared of having sex following a heart attack, prompting Quoteboffin.co.uk to release a statement encouraging those with heart problems to speak to doctors to allay their fears.

Quoteboffin.co.uk Encourages Heart Attack Survivors To Speak To Doctors About Sex Fears

A team of US researchers questioned 1,700 heart attack survivors and discovered that around a third reported they were less likely to be having more sex a year on from the date of their attack. Many reported that the fear that sex could kill them was a major factor in deciding to abstain, the researchers told the American Heart Association.

The study was led by Dr Stacy Tessler Lindau, who explained that the chance of suffering subsequent attacks during sex were very small, as long as it is at an appropriate time in the recovery process – an opinion also backed by the British Heart Foundation.

Most patients should be able to resume sexual activity at the same time as they become physically able to partake in moderate exercise, such as climbing a flight of stairs.

The research also found that the patients who were not counselled in sex by their doctors were more likely to avoid it. This news has prompted health insurance comparison site Quoteboffin.co.uk to issue a statement encouraging patients to speak to their doctors about all of their concerns. It said: “While it may be the last thing on the minds’ of patients immediately after a heart attack, it’s natural for questions concerning sex to arise as recovery progresses.

“However, by this point, many people may feel they aren’t able to go back to their doctor, or be too shy to raise the question. It’s very important that people feel confident in seeking information and speaking to medical professionals about sex after serious health scares, and this study highlights the importance of doctors making sure patients are well informed of all of the facts from the outset.”

The study, which examined the sex lives of 1,184 men and 576 women in the year following a heart attack, found that patients who had been given a leaflet about sex when they were discharged from hospital were more likely to resume their sex life.

Via EPR Network
More Healthcare press releases

FDA Blunder and Cover-up Kills Millions

The World Health Organization (WHO) has just recommended that drinking water contain 25-50 mg of magnesium (Mg) per liter to prevent deaths from heart attack and stroke. MgWater.com/download American bottled water averages <5 mg of magnesium per liter, while bottled water in the rest of the world averages about 20 mg of magnesium per liter.

FDA Blunder and Cover-up Kills Millions

The FDA and DOJ caused the Mg-deficient-water problem by destroying the American mineral water industry in the 1930’s, in the mistaken belief that pure water was good, and that mineral water was just impure water.

Epidemiological studies indicate that millions of Americans have died due to the FDA’s and DOJ’s destruction of the American mineral water industry. See:
http://www.mgwater.com/anderson.shtml
http://www.mgwater.com/lancet.shtml
http://www.mgwater.com/finland.shtml
http://www.mgwater.com/singh.shtml

For decades, the evidence has been overwhelming that Americans are very deficient in Mg, as evidenced by the 23% shortfall from the RDI, yet the FDA and DOJ have covered up their blunder, getting a Federal lawsuit dismissed before the evidence could be shown, and keeping silent about the millions of deaths indicated by over 50 epidemiological studies from nine countries.

Now, it is up to the FDA and DOJ to end this travesty, requiring the Mg content of bottled or canned beverages to be put in labels’ nutrition panels, and requiring that all bottled or canned beverages contain at least 25 mg of Mg per liter.

Foods no longer contain as much magnesium as they did a century ago, due to increased food processing and possible soil depletion. Consumers have generally rejected magnesium-rich whole grain foods like brown rice and brown bread, in favor of magnesium-stripped white rice and white bread. Bottled beverages are the most practical way of delivering magnesium to consumers.

Recent studies clearly confirm that water-borne Mg is far, far better in preventing cardiovascular pathologies than food-borne Mg. For more information, go to the Magnesium Online Library at www.MgWater.com.

Via EPR Network
More Healthcare press releases

GoodToBeAlive.Com Launches National Retail Outlet For Defibrillators Exclusively For Home Users

Good To Be Alive launches its primary retail channel, www.GoodToBeAlive.com and toll-free number 1-888-OWN-1-AED (1-888-696-1233), which is a one-of-a-kind retail outlet – the nation’s first exclusive-for-home seller of defibrillators (automated external defibrillators or AEDs) suitable for personal use. Good To Be Alive offers Personal-AEDs or automated external defibrillators, (sometimes referred to as a Portable AED) which are self-contained laptop-sized devices that are used to revive a person suffering from sudden cardiac arrest by delivering a controlled electrical shock that can reset the heart to normal function. For witnessed sudden cardiac arrest, if used immediately, AEDs are up to 90% successful at resuscitation (whereas without an AED readily available, survival rates are 1% – 5%). Until recently, these devices were only safe when used by a trained professional. Now, due to recent technological advances, Personal-AEDs are safe and easy for layperson use. No other consumer device has empowered individuals for such dramatic results – resuscitation of a sudden cardiac arrest victim – basically bringing someone back to life!

SUDDEN CARDIAC ARREST BACKGROUND:

Knowing the facts reveals the need for personal AEDs in homes: Sudden cardiac arrest is the leading cause of death in the United States. More than 300,000 US deaths annually, across all demographics, are attributed to sudden cardiac arrest (more than breast cancer, prostate cancer, house fires, hand guns, traffic accidents, and AIDS combined). Tens of thousands of sudden cardiac arrest deaths could be prevented if an AED were used immediately. AED utilization is the only treatment for sudden cardiac arrest – survival odds decrease 10% every minute without an AED. Few attempts at resuscitation are successful after 10 minutes without an AED. It is crucial to recognize that the majority of sudden cardiac arrest victims are asymptomatic, meaning these victims were not at heightened risk for a heart attack. We are all at risk, including the youngest among us. Sudden cardiac arrest is not limited to the aging population. Approximately 22% of sudden deaths for people between 1 and 21 years of age are due to cardiac arrest. A final relevant statistic– 80% of cardiac arrest occurs at home.

PURPOSE, NON-PROFIT PARTNERSHIP:

Good To Be Alive partners with national non-profit Sudden Cardiac Arrest Foundation (www.sca-aware.org). Initially, the two organizations are presenting survivor stories to the public, offering a referral purchase program (that will result in donations from Good To Be Alive to the SCA Foundation), and looking ahead to developing a public awareness campaign called “Save A Life at Home”, which will follow the successful and ongoing SCA Foundation campaign “Save A life at School.”

“Good To Be Alive is focused on providing defibrillators in the home where they are needed most. We are grateful that Good To Be Alive has chosen to begin supporting our Foundation from the onset, this is a demonstration of their commitment to their mission to save lives,” said Mary Newman, the President of the SCA Foundation.

Mark Adelman is the founding partner of Good To Be Alive. Mr. Adelman and senior partner, Allan Fine, are currently test marketing, as well as honing website and logistical operations. The senior management team expects Good To Be Alive to locally employ 12+ individuals by Fall 2010 in a combination of management and member support positions.

“I’ve always focused on technology serving people – I see that society is far too slowly adopting this life-extending medical advancement. The latest generation of easy-to-use AEDs are a game changer against the nation’s number one cause of death – sudden cardiac arrest. We’re determined to put a Personal-AED in the hands of as many people as possible. Our purpose is to decrease loss of life from sudden cardiac arrest. The American Heart Association estimates that between 50,000 – 100,000 lives could be saved annually if AEDs were widely accessible. That said, in the end, the decision to protect yourself and the people you care about against sudden cardiac arrest is a personal choice, it’s the individual’s right to choose to be prepared,” founding partner Mr. Adelman said.

Senior partner Mr. Fine said, “We applaud the proliferation of public access AEDs. The AEDs we all see in airports, fitness centers, and schools are important for people to have available, however the public should understand that 80% of sudden cardiac arrest occurs in the home. We are placing Personal-AEDs in people’s homes, where they are needed most. Good To Be Alive’s mission to save lives is very personal for me due to the fact that last year I lost my 28 year old brother to sudden cardiac arrest in his home. When Personal-AEDs are widely accessible, similar tragic losses can be avoided for other families.”

Good To Be Alive has established the Good To Be Alive Foundation. The Foundation’s purpose is to give back to the community by supporting the proliferation of AEDs, both Personal-AEDs and public-access AEDs (located at schools, airports, etc.) In fact, the Good To Be Alive Foundation has already donated AED equipment to a local high school and an AED to a county-based EMS group. Additionally, the Good To Be Alive Foundation is partnering with the Sudden Cardiac Arrest Foundation (www.sca-aware.org) to support its efforts for a developing “Save A Life at Home” awareness campaign.

GOOD TO BE ALIVE TEAM BACKGROUND:

Founding partner, attorney Mark Adelman is a graduate of the Georgia State College of Law and the University of Georgia, Grady College of Journalism, as well as an experienced healthcare administrator. Prior to becoming a member of the Georgia Bar Association (2000), Mr. Adelman contributed to the development of the CNN brand as a producer in the network’s Marketing and Creative Services division. More recently, he won national video production awards for Georgia Tech as part of their marketing efforts. Mr. Adelman is an American Red Cross certified AED Instructor.

Via EPR Network
More
Healthcare press releases

The Facts About Heart Disease

  • Heart Disease has been the number 1 killer in the US every year since 1900 with the exception of 1918.

  • At least 250,000 Americans die of heart attacks each year before they reach the hospital.

  • Every 34 seconds someone in the US dies from Heart Disease.

  • Heart Disease can be avoided with good nutrition.
If you are as little as 10 pounds overweight you are at risk forHeart Disease.Chronic Diseases cost the US economy 1.3 trillion dollars annually and this could reach 6 trillion by the middle of the century.

Reduce the Risk of Heart Disease for you and your loved ones. Over and over again I hear success stories of how people who have used our science based, nutritional products to lose weight. But not only do they lose weight but they are lowering their cholesterol levels, stabilizing blood pressure and sugar levels and are getting off of medications they have been taking for years. We have had people say they have gotten rid of allergies, migraines, joint pain and more. Good Nutrition allows your body to heal. (individual results vary). You can gain weight, lose weight, or maintain weight with our products. Our products do come with a guarantee.

My mother and father have both had open heart surgery. It is not a fun thing to go through. The thought of having your breast bone broken in half and raised in vertical position for hours is not a pretty picture to me. I do not wish to ever need this surgery and I am here to help you, in hopes that you do not ever need it as well.

Good Nutrition affects everything:

  • health

  • energy

  • organs

  • cells

  • vitality

  • skin

  • quality of life

The American Medical Association has said that 70% of medical conditions are diet related.

Here are a few common diseases that may be prevented with proper diet and or maintaining a healthy weight.

Cancer: breast, uterus, cervix, colon, esophagus, pancreas, kidney and prostrate
Coronary Heart Disease, Diabetes, Dyslipidemia, hypertension
Idiopathic Intacraial hypertension, stroke, cataracts
Osteoarthritis, skin, gout, phlebitis
Gynecologic Abnormalities, abnormal menses,infertility, poly cystic ovarian syndrome
Gall Bladder Disease
Pulmonary Disease
Obstructive Sleep Apnea
Hypo ventilation Syndrome
Severe Pancreatitis
Non Alcoholic Fatty Liver Disease

If you truly want to feel good and enjoy quality of life you need to get started with Core Nutrition. Once you receive your Core Nutrition, I will send you a personalize your program DVD (FREE), I will give you personalized coaching on a regular basis (FREE) to help you achieve your wellness goals, and you will receive a FREE Wellness Evaluation. A Wellness Evaluation will help you learn better dieting habits as well as give you a better understanding about where you are at with your health and wellness. We will be able to determine what your goals are and come up with some recommendations that will help you be able to enjoy a better quality of life.

Once you get started with our Core Nutrition or Weight Loss Program you may find that you are saving money on your prescriptions plus doctor and hospital bills. You may even be earning more money because you are missing work less and are able to work longer hours.

Via EPR Network
More Healthcare press releases

Officials From East Carolina University And University Health Systems Of Eastern Carolina Dedicated The East Carolina Heart Institute Today

Officials from East Carolina University and University Health Systems of Eastern Carolina dedicated the East Carolina Heart Institute today. Several hundred invited guests joined leaders from the two organizations to celebrate the facility. The Heart Institute puts ECU and Pitt County Memorial Hospital “at the forefront of progress and the cutting edge of the future,” said Dr. W. Randolph Chitwood, director of the East Carolina Heart Institute.

“What we dedicate today is a concept called the East Carolina Heart Institute that encompasses these new facilities, dedicated to the people of this region, and to the physicians, researchers, educators and staff devoted to their care,” said Chitwood, who is cardiothoracic surgery and vascular surgery at the Brody School of Medicine at ECU. He is also senior associate vice chancellor for health sciences at ECU.

The dedication ceremony, held at the East Carolina Heart Institute at ECU, capped more than four years of work to bring a world-class cardiovascular disease institute to eastern North Carolina. In 2004, the General Assembly approved $60 million for a research, education and outpatient care facility at ECU. Pitt County Memorial Hospital secured private funding for a $160 million bed tower. Today, leaders from the two organizations celebrated the end of construction on both facilities.

Many who attended the ceremony also toured the two facilities after the event ended. The crowd included local and state officials, donors and other friends of each organization.

The celebration marked “the most significant collaboration University Health Systems and East Carolina University have ever undertaken,” said UHS CEO Dave McRae. “It’s the biggest step of a journey we started more than 30 years ago, when a small county hospital and a fledgling medical school committed to forming the world-class academic medical center we’re part of today,” McRae said.

ECU and PCMH have been “joined at the hip” for decades, ECU Chancellor Steve Ballard said. “The East Carolina Heart Institute is the latest partnership between us, and it will make a major and lasting impact in eastern North Carolina, the entire state and beyond,” Ballard said.

The new buildings aren’t the only sign of a new approach to heart disease for ECU and PCMH. The two organizations have also redefined their model for treating cardiovascular illnesses. Both have organized their clinical staffs around illnesses and disease processes, rather than following a traditional model based on academic specialties. That new model encourages more information-sharing among doctors and puts new emphasis on patients’ best interests, Chitwood said. “This new model of care delivery is an innovative way to blend the science and art of medicine so that we add value to the patient,” Chitwood said.

The prevalence of cardiovascular disease in North Carolina justifies the massive investment in treating and researching heart and vascular illnesses. Cardiovascular disease is the second-leading cause of death in the state, and nearly a quarter of N.C. residents suffer from cardiovascular ailments.

Planning for the East Carolina Heart Institute dates to early 2003. ECU and PCMH held a groundbreaking for the Heart Institute in March 2006. In addition to the six-story 375,000-square-foot bed tower, the Heart Institute at Pitt County Memorial Hospitalspawned a pair of companion projects: construction of a massive central utility plant to power the new building and the relocation of Moye Boulevard.

The Heart Institute at Pitt County Memorial Hospital has 120 cardiovascular beds, six operating rooms, seven interventional laboratories, three electrophysiology labs and a heart-healthy cafeteria, all designed to create the optimal patient care environment.

The four-story, 206,000-square-foot East Carolina Heart Institute at ECU houses science and clinical research, robotic-surgery training, future space for simulation laboratories, a clinical outpatient facility for cardiovascular diseases, a database center, offices and an auditorium.

The Heart Institute at Pitt County Memorial Hospital will open Jan. 5. ECU physicians have been seeing patients at the East Carolina Heart Institute at ECU since September. For more information please visit www.eastcarolinaheartinstitute.com

Via EPR Network
More Healthcare press releases

 

Lloydspharmacy Campaign Against The Threat Of Coronary Heart Disease Joined By Royle Family Star Ricky Tomlinson

Actor Ricky Tomlinson has warned British men against the threat of Coronary Heart Disease (CHD) as part of a new campaign for Lloydspharmacy. Ricky freely admits that he did not take his heart health seriously in the past and paid the price in 2007 when he was diagnosed with heart disease after his wife insisted that he went to the doctor for a check-up.

A quadruple bypass and a significant amount of weight loss later, Ricky says he is a new man. He admits that if his wife hadn’t mentioned to his doctor that he had been a little breathless, he would probably be either very ill now, or worse.

Tomlinson’s campaign, ‘Ten Years Longer’, is designed to encourage men who are at risk of CHD to get their hearts checked out. “Men think illness is the same as weakness and it’s not very manly to be ill,” said Ricky. “The trouble with that is that if you ignore your health then you are more likely to get very ill indeed.”

He continued, “If women will go on a TV show to look ten years younger, then men can go to a pharmacy to live ten years longer.”

According to a new study by Lloydspharmacy, CHD will rob British men of more than 16.5 million years of life, although early detection of cardiovascular problems could lead to 4.3 million of those years being saved. That’s an average of 4 years per at-risk individual, but for some the number of additional years could be much greater.

Andy Murdock, Pharmacy Director for Lloydspharmacy said: “Most men can manage to keep the appointments that they think are important. They get their cars serviced, get to meetings on time and remember to file their tax returns. The one appointment they can’t seem to make is for a health check up.”

Lloydspharmacy offers cholesterol and heart checks at 625 of its pharmacies across the UK. The Lloydspharmacy cholesterol and heart check removes many of the excuses men typically give for not getting themselves checked out. No appointment is necessary so they can just walk into the chemist off the street at a time which is convenient.

Dr David Grainger, a heart disease researcher at Cambridge University and British Heart Foundation Senior Fellow, who compiled the Lloydspharmacy study, said, “When my father died suddenly from a heart attack at the age of 55, he had no idea there was any problem with his heart. But this study emphasises that despite improvements over the last decade, heart disease still has a huge impact on the health of the UK population, and men in particular. The first step to avoiding a heart attack is being aware of the risks.”

About The Lloydspharmacy Heart Healthcheck
The 15 minute Lloydspharmacy Heart Healthcheck checks cholesterol, blood pressure, blood glucose and body mass index as well as giving a full lifestyle assessment. Based on these results a percentage risk score of developing heart disease over the next ten years is estimated. Everyone who uses the free service will receive a personal action plan and summary of the test results. For high-risk customers a support pack is supplied and referral to the GP is recommended.

The Heart Healthcheck was trialled in 122 Lloydspharmacy outlets across the country last year and results show approximately 40% of those who had a check were referred to their GP.

Via EPR Network
More Healthcare press releases